Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Extended survival with Left Ventricular Assist Devices (LVADs) has increased interest in their use for ambulatory patients with advanced heart failure (HF).
• Current limitations exist in defining indications for LVAD implantation in less critically ill advanced HF patients.

Purpose of the Study:

• To review current understanding and decision-making for LVAD implantation in ambulatory advanced HF patients.
• To explore the prognostic information and decision-making guidance from studies like MedaMACS and ROADMAP.
• To highlight the need for individualized risk-benefit assessments beyond survival for LVAD candidates.

Main Methods:

• Review of findings from the MedaMACS and ROADMAP studies.
• Analysis of prognostic indicators and patient profiles (e.g., INTERMACS profiles) in advanced HF.
• Discussion of shared decision-making principles for LVAD therapy.

Main Results:

• Sicker INTERMACS profiles correlate with a higher risk of death or requiring a rescue LVAD.
• Ambulatory patients in INTERMACS profile 4 may be suitable candidates for LVADs due to high mortality and poor quality of life.
• Studies reveal discrepancies in perceived HF severity between patients and physicians.

Conclusions:

• LVADs can be considered for carefully selected ambulatory advanced HF patients, particularly those in INTERMACS profile 4.
• Shared decision-making is crucial, involving a nuanced evaluation of risks and benefits beyond mere survival.
• Future research, including the REVIVAL study, will further inform prognostic understanding and guide complex LVAD therapy decisions.